340 related articles for article (PubMed ID: 15996977)
1. Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases.
Jochmann N; Stangl K; Garbe E; Baumann G; Stangl V
Eur Heart J; 2005 Aug; 26(16):1585-95. PubMed ID: 15996977
[TBL] [Abstract][Full Text] [Related]
2. [Sex differences and cardiovascular drugs].
Løchen ML; Kvan E
Tidsskr Nor Laegeforen; 2010 Feb; 130(4):382-4. PubMed ID: 20220863
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular drug therapy in the elderly.
Aronow WS; Frishman WH; Cheng-Lai A
Cardiol Rev; 2007; 15(4):195-215. PubMed ID: 17575484
[TBL] [Abstract][Full Text] [Related]
4. Gender, ethnicity, and genes in cardiovascular disease. Part 2: implications for pharmacotherapy.
Schaefer BM; Caracciolo V; Frishman WH; Charney P
Heart Dis; 2003; 5(3):202-14. PubMed ID: 12783634
[TBL] [Abstract][Full Text] [Related]
5. [Drugs used in cardiovascular diseases and cytokines].
Andrzejczak D; Górska D
Wiad Lek; 2006; 59(3-4):232-7. PubMed ID: 16813270
[TBL] [Abstract][Full Text] [Related]
6. Pharmacotherapy in patients with stable coronary artery disease treated on an outpatient basis in Poland. Results of the multicentre RECENT study.
Banasiak W; Wilkins A; Pociupany R; Ponikowski P
Kardiol Pol; 2008 Jun; 66(6):642-9; discussion 650. PubMed ID: 18626833
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein (CRP)-lowering agents.
Prasad K
Cardiovasc Drug Rev; 2006; 24(1):33-50. PubMed ID: 16939632
[TBL] [Abstract][Full Text] [Related]
8. Evidence-based use of medications in patients with coronary artery disease in a rural Australian community.
Granmyr J; Ball P; Curran S; Wang L
Aust J Rural Health; 2007 Aug; 15(4):241-6. PubMed ID: 17617087
[TBL] [Abstract][Full Text] [Related]
9. Cardiac medication in the perioperative period.
Wallner T; Preis C; Mayer N
Acta Anaesthesiol Scand Suppl; 1997; 111():22-8. PubMed ID: 9420942
[No Abstract] [Full Text] [Related]
10. [Cardiovascular pharmacotherapy in old age: How beneficial is it? What does it cost?].
Gysling E
Praxis (Bern 1994); 1995 Oct; 84(44):1248-51. PubMed ID: 7491446
[TBL] [Abstract][Full Text] [Related]
11. [Progress in cardiovascular pharmacology].
Zhu JR
Zhonghua Xin Xue Guan Bing Za Zhi; 1993 Dec; 21(6):358-60. PubMed ID: 7913889
[No Abstract] [Full Text] [Related]
12. Cardiovascular drugs: effects on exercise testing and exercise training of the coronary patient.
Wenger NK
Cardiovasc Clin; 1985; 15(2):133-43. PubMed ID: 2868791
[TBL] [Abstract][Full Text] [Related]
13. Sex and gender differences in cardiovascular drug therapy.
Seeland U; Regitz-Zagrosek V
Handb Exp Pharmacol; 2012; (214):211-36. PubMed ID: 23027453
[TBL] [Abstract][Full Text] [Related]
14. Drug secondary prevention in postmenopausal women with ischemic heart disease.
Zdrenghea D; Pop D; Sitar-Tăut A; Cebanu M; Zdrenghea V
Rom J Intern Med; 2009; 47(1):41-5. PubMed ID: 19886068
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of drug therapy in the secondary prevention of cardiovascular disease and stroke.
Fletcher GF; Bufalino V; Costa F; Goldstein LB; Jones D; Smaha L; Smith SC; Stone N
Am J Cardiol; 2007 Mar; 99(6C):1E-35E. PubMed ID: 17378996
[No Abstract] [Full Text] [Related]
16. Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study.
Rejnmark L; Vestergaard P; Mosekilde L
J Hypertens; 2006 Mar; 24(3):581-9. PubMed ID: 16467662
[TBL] [Abstract][Full Text] [Related]
17. Risk factor profiles and use of cardiovascular drug prevention in women and men with peripheral arterial disease.
Sigvant B; Wiberg-Hedman K; Bergqvist D; Rolandsson O; Wahlberg E
Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):39-46. PubMed ID: 19237996
[TBL] [Abstract][Full Text] [Related]
18. Gender differences in pharmacokinetics and pharmacodynamics.
Beierle I; Meibohm B; Derendorf H
Int J Clin Pharmacol Ther; 1999 Nov; 37(11):529-47. PubMed ID: 10584975
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic implications of the gender-specific aspects of cardiovascular disease.
Regitz-Zagrosek V
Nat Rev Drug Discov; 2006 May; 5(5):425-38. PubMed ID: 16672926
[TBL] [Abstract][Full Text] [Related]
20. [The role of genetic polymorphisms of cytochrome P450 in drug metabolism used in the treatment of cardiovascular diseases].
Wojtczak A; Skretkowicz J
Kardiol Pol; 2009 Sep; 67(9):1011-4. PubMed ID: 19838960
[No Abstract] [Full Text] [Related]
[Next] [New Search]
